CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 9 years ago You may also like 50:55 Weekend Steroids and Exercise for Duchenne (March 3, 2021) 4 years ago Research & Clinical Trial Webinars,Webinars 42:48 Family Friday: Independent Living (January 29, 2021) 4 years ago Family Friday,For Teens & Adults,Webinars 1:01:12 Planning For Your Future: Navigating Benefits & Finances (January 28, 2021) 4 years ago Care Webinars,Webinars 43:57 PPMD’s Biomarkers Initiative 4 years ago Research & Clinical Trial Webinars,Webinars 58:56 COVID-19 Vaccination & Duchenne: What You Need To Know (December 11, 2020) 4 years ago Care Webinars,COVID-19 Webinars,Webinars 1:24:49 SRP-9001 Gene Therapy Path Forward (November 24, 2020) 4 years ago Research & Clinical Trial Webinars,Webinars gene therapy 1:01:09 Connect with the Experts: Endocrine Series – Height and Weight 4 years ago Care Webinars,Webinars 50:05 Catabasis Phase 3 PolarisDMD Trial Results (October 27, 2020) 4 years ago Research & Clinical Trial Webinars,Webinars «1…7891011…25»Page 9 of 25
by: Parent Project Muscular Dystrophy
